Test Bank: Julien's Primer of Drug Action, 15th Edition
PART 1: INTRODUCTION TO PSYCHOPHARMACOLOGY: THE
BIOLOGICAL BASIS OF DRUG ACTION
Chapter 1: Pharmacokinetics: How the Body Handles Drugs
Question 1:
Pharmacokinetics involves the study of:
A) The biochemical and physiological effects of drugs and their mechanisms of action.
B) The movement of drugs into, through, and out of the body (absorption, distribution,
metabolism, and excretion).
C) The structural relationship between a drug and its receptor.
D) The study of poisons and the treatment of poisoning.
Answer: B) The movement of drugs into, through, and out of the body (absorption,
distribution, metabolism, and excretion).
Rationale: Pharmacokinetics is often summarized as "what the body does to the drug." It
describes the processes of absorption (entering the bloodstream), distribution (reaching
tissues), metabolism (chemical alteration, often by the liver), and excretion (elimination from
the body). In contrast, pharmacodynamics is "what the drug does to the body" (Option A).
Question 2:
The first-pass effect is a phenomenon where:
A) A drug is excreted unchanged by the kidneys before it can be distributed.
B) A drug's concentration is reduced by metabolism in the liver before it reaches the
systemic circulation.
C) The drug must bind to plasma proteins to be transported effectively.
D) A drug is absorbed directly into the bloodstream via the sublingual route.
Answer: B) A drug's concentration is reduced by metabolism in the liver before it reaches the
systemic circulation.
Rationale: When a drug is absorbed from the gastrointestinal tract, it travels via the hepatic
portal system to the liver. The liver may metabolize a significant portion of the drug before it
enters the general circulation, reducing its bioavailability. This is known as the first-pass
effect and is a key reason why some drugs must be administered via routes that bypass the
liver (e.g., intravenous, sublingual) to be effective.
Question 3:
Bioavailability refers to:
A) The percentage of an administered drug that reaches the systemic circulation.
B) The speed at which a drug is excreted from the body.
C) The amount of drug that binds to plasma proteins.
,D) The extent to which a drug produces side effects.
Answer: A) The percentage of an administered drug that reaches the systemic circulation.
Rationale: Bioavailability is the fraction of an administered dose of unchanged drug that
reaches the systemic circulation. It is influenced by factors such as absorption, first-pass
metabolism, and the route of administration. Intravenous administration provides 100%
bioavailability, while oral drugs often have lower bioavailability due to first-pass metabolism.
Question 4:
The volume of distribution (Vd) is a pharmacokinetic parameter that:
A) Represents the actual volume of blood in the body.
B) Relates the amount of drug in the body to the concentration of drug in the plasma.
C) Measures the rate at which a drug is metabolized by the liver.
D) Indicates the amount of drug that is bound to plasma proteins.
Answer: B) Relates the amount of drug in the body to the concentration of drug in the
plasma.
Rationale: The volume of distribution is a theoretical concept that describes how extensively
a drug distributes from the plasma into other body tissues and fluids. A large Vd indicates
that the drug is widely distributed throughout the body tissues, while a small Vd suggests
the drug remains primarily in the plasma.
Question 5:
Which route of administration has the fastest onset of action?
A) Oral
B) Subcutaneous
C) Intramuscular
D) Intravenous
Answer: D) Intravenous
Rationale: Intravenous administration places the drug directly into the bloodstream,
bypassing all absorption barriers. This results in the most rapid onset of action and 100%
bioavailability. Other routes require absorption through biological membranes before the
drug reaches systemic circulation, delaying onset.
Question 6:
The half-life of a drug is defined as:
A) The time required for the drug to be completely eliminated from the body.
B) The time required for the drug's plasma concentration to decrease by 50%.
C) The time required for the drug to reach peak plasma concentration.
D) The time required for the drug to produce its maximum therapeutic effect.
Answer: B) The time required for the drug's plasma concentration to decrease by 50%.
,Rationale: Half-life (t½) is a pharmacokinetic parameter that describes the rate at which a
drug is eliminated from the body. It represents the time needed for the plasma
concentration of the drug to fall by 50%. Approximately 5 half-lives are required for a drug to
be considered essentially eliminated from the body (about 97%).
Question 7:
Drugs that are weak acids or weak bases can become:
A) Ionized or non-ionized depending on the pH of the environment.
B) Completely metabolized before absorption.
C) Excreted only through the kidneys.
D) Bound irreversibly to plasma proteins.
Answer: A) Ionized or non-ionized depending on the pH of the environment.
Rationale: The ionization state of a weak acid or weak base depends on the pH of the
surrounding environment and the drug's pKa (the pH at which the drug is 50% ionized). Only
the non-ionized (lipophilic) form can readily cross biological membranes, which is crucial for
absorption, distribution, and excretion.
Question 8:
The primary organ responsible for drug metabolism is the:
A) Kidney.
B) Liver.
C) Lung.
D) Intestine.
Answer: B) Liver.
Rationale: The liver is the primary site of drug metabolism, containing a variety of enzymes,
particularly the cytochrome P450 (CYP450) system, that chemically modify drugs. These
metabolic reactions typically convert lipophilic drugs into more hydrophilic metabolites that
can be more easily excreted by the kidneys. While other organs also contribute to
metabolism, the liver is the most significant.
Question 9:
Which of the following statements about drug excretion is correct?
A) Drugs are primarily excreted through the lungs.
B) The kidneys are the primary organs for excretion of drugs and their metabolites.
C) Biliary excretion is the only route of drug elimination.
D) Drugs cannot be excreted through sweat or saliva.
Answer: B) The kidneys are the primary organs for excretion of drugs and their metabolites.
Rationale: The kidneys filter the blood and excrete drugs and their metabolites in urine. This
is the most important route of drug elimination. Other routes include biliary excretion
(through the liver into feces), pulmonary excretion (for volatile substances), and excretion
through sweat, saliva, and breast milk (minor routes).
, Question 10:
The cytochrome P450 enzyme system is important because:
A) It is responsible for drug absorption in the gastrointestinal tract.
B) It metabolizes many drugs and can be affected by drug interactions.
C) It transports drugs across the blood-brain barrier.
D) It is the primary receptor for most psychoactive drugs.
Answer: B) It metabolizes many drugs and can be affected by drug interactions.
Rationale: The CYP450 enzyme system, located primarily in the liver, is responsible for
metabolizing a wide variety of drugs. These enzymes can be induced (increasing metabolism
and decreasing drug effectiveness) or inhibited (decreasing metabolism and increasing the
risk of toxicity) by other drugs, leading to significant drug-drug interactions.
Question 11:
Zero-order kinetics describes a situation where:
A) The rate of drug elimination is proportional to the drug concentration.
B) A constant amount of drug is eliminated per unit time, regardless of concentration.
C) The drug is eliminated exponentially.
D) The drug's half-life remains constant.
Answer: B) A constant amount of drug is eliminated per unit time, regardless of
concentration.
Rationale: Zero-order kinetics occurs when the elimination mechanisms are saturated, and a
constant amount of drug is eliminated per unit time. This is in contrast to first-order kinetics,
where a constant fraction of the drug is eliminated per unit time (elimination is proportional
to concentration). Alcohol is a classic example of a drug that follows zero-order elimination
at high concentrations.
Question 12:
The blood-brain barrier restricts the entry of drugs into the brain primarily because:
A) Brain capillaries have tight junctions and are surrounded by astrocytic foot processes.
B) There is no blood supply to the brain.
C) The brain has no receptors for drugs.
D) Drugs are metabolized before reaching the brain.
Answer: A) Brain capillaries have tight junctions and are surrounded by astrocytic foot
processes.
Rationale: The blood-brain barrier consists of specialized endothelial cells in brain capillaries
that are connected by tight junctions, preventing the free passage of many substances.
Astrocytes (glial cells) contribute to maintaining this barrier. Only lipophilic (lipid-soluble)
drugs can cross the blood-brain barrier and exert central nervous system effects.
Question 13:
PART 1: INTRODUCTION TO PSYCHOPHARMACOLOGY: THE
BIOLOGICAL BASIS OF DRUG ACTION
Chapter 1: Pharmacokinetics: How the Body Handles Drugs
Question 1:
Pharmacokinetics involves the study of:
A) The biochemical and physiological effects of drugs and their mechanisms of action.
B) The movement of drugs into, through, and out of the body (absorption, distribution,
metabolism, and excretion).
C) The structural relationship between a drug and its receptor.
D) The study of poisons and the treatment of poisoning.
Answer: B) The movement of drugs into, through, and out of the body (absorption,
distribution, metabolism, and excretion).
Rationale: Pharmacokinetics is often summarized as "what the body does to the drug." It
describes the processes of absorption (entering the bloodstream), distribution (reaching
tissues), metabolism (chemical alteration, often by the liver), and excretion (elimination from
the body). In contrast, pharmacodynamics is "what the drug does to the body" (Option A).
Question 2:
The first-pass effect is a phenomenon where:
A) A drug is excreted unchanged by the kidneys before it can be distributed.
B) A drug's concentration is reduced by metabolism in the liver before it reaches the
systemic circulation.
C) The drug must bind to plasma proteins to be transported effectively.
D) A drug is absorbed directly into the bloodstream via the sublingual route.
Answer: B) A drug's concentration is reduced by metabolism in the liver before it reaches the
systemic circulation.
Rationale: When a drug is absorbed from the gastrointestinal tract, it travels via the hepatic
portal system to the liver. The liver may metabolize a significant portion of the drug before it
enters the general circulation, reducing its bioavailability. This is known as the first-pass
effect and is a key reason why some drugs must be administered via routes that bypass the
liver (e.g., intravenous, sublingual) to be effective.
Question 3:
Bioavailability refers to:
A) The percentage of an administered drug that reaches the systemic circulation.
B) The speed at which a drug is excreted from the body.
C) The amount of drug that binds to plasma proteins.
,D) The extent to which a drug produces side effects.
Answer: A) The percentage of an administered drug that reaches the systemic circulation.
Rationale: Bioavailability is the fraction of an administered dose of unchanged drug that
reaches the systemic circulation. It is influenced by factors such as absorption, first-pass
metabolism, and the route of administration. Intravenous administration provides 100%
bioavailability, while oral drugs often have lower bioavailability due to first-pass metabolism.
Question 4:
The volume of distribution (Vd) is a pharmacokinetic parameter that:
A) Represents the actual volume of blood in the body.
B) Relates the amount of drug in the body to the concentration of drug in the plasma.
C) Measures the rate at which a drug is metabolized by the liver.
D) Indicates the amount of drug that is bound to plasma proteins.
Answer: B) Relates the amount of drug in the body to the concentration of drug in the
plasma.
Rationale: The volume of distribution is a theoretical concept that describes how extensively
a drug distributes from the plasma into other body tissues and fluids. A large Vd indicates
that the drug is widely distributed throughout the body tissues, while a small Vd suggests
the drug remains primarily in the plasma.
Question 5:
Which route of administration has the fastest onset of action?
A) Oral
B) Subcutaneous
C) Intramuscular
D) Intravenous
Answer: D) Intravenous
Rationale: Intravenous administration places the drug directly into the bloodstream,
bypassing all absorption barriers. This results in the most rapid onset of action and 100%
bioavailability. Other routes require absorption through biological membranes before the
drug reaches systemic circulation, delaying onset.
Question 6:
The half-life of a drug is defined as:
A) The time required for the drug to be completely eliminated from the body.
B) The time required for the drug's plasma concentration to decrease by 50%.
C) The time required for the drug to reach peak plasma concentration.
D) The time required for the drug to produce its maximum therapeutic effect.
Answer: B) The time required for the drug's plasma concentration to decrease by 50%.
,Rationale: Half-life (t½) is a pharmacokinetic parameter that describes the rate at which a
drug is eliminated from the body. It represents the time needed for the plasma
concentration of the drug to fall by 50%. Approximately 5 half-lives are required for a drug to
be considered essentially eliminated from the body (about 97%).
Question 7:
Drugs that are weak acids or weak bases can become:
A) Ionized or non-ionized depending on the pH of the environment.
B) Completely metabolized before absorption.
C) Excreted only through the kidneys.
D) Bound irreversibly to plasma proteins.
Answer: A) Ionized or non-ionized depending on the pH of the environment.
Rationale: The ionization state of a weak acid or weak base depends on the pH of the
surrounding environment and the drug's pKa (the pH at which the drug is 50% ionized). Only
the non-ionized (lipophilic) form can readily cross biological membranes, which is crucial for
absorption, distribution, and excretion.
Question 8:
The primary organ responsible for drug metabolism is the:
A) Kidney.
B) Liver.
C) Lung.
D) Intestine.
Answer: B) Liver.
Rationale: The liver is the primary site of drug metabolism, containing a variety of enzymes,
particularly the cytochrome P450 (CYP450) system, that chemically modify drugs. These
metabolic reactions typically convert lipophilic drugs into more hydrophilic metabolites that
can be more easily excreted by the kidneys. While other organs also contribute to
metabolism, the liver is the most significant.
Question 9:
Which of the following statements about drug excretion is correct?
A) Drugs are primarily excreted through the lungs.
B) The kidneys are the primary organs for excretion of drugs and their metabolites.
C) Biliary excretion is the only route of drug elimination.
D) Drugs cannot be excreted through sweat or saliva.
Answer: B) The kidneys are the primary organs for excretion of drugs and their metabolites.
Rationale: The kidneys filter the blood and excrete drugs and their metabolites in urine. This
is the most important route of drug elimination. Other routes include biliary excretion
(through the liver into feces), pulmonary excretion (for volatile substances), and excretion
through sweat, saliva, and breast milk (minor routes).
, Question 10:
The cytochrome P450 enzyme system is important because:
A) It is responsible for drug absorption in the gastrointestinal tract.
B) It metabolizes many drugs and can be affected by drug interactions.
C) It transports drugs across the blood-brain barrier.
D) It is the primary receptor for most psychoactive drugs.
Answer: B) It metabolizes many drugs and can be affected by drug interactions.
Rationale: The CYP450 enzyme system, located primarily in the liver, is responsible for
metabolizing a wide variety of drugs. These enzymes can be induced (increasing metabolism
and decreasing drug effectiveness) or inhibited (decreasing metabolism and increasing the
risk of toxicity) by other drugs, leading to significant drug-drug interactions.
Question 11:
Zero-order kinetics describes a situation where:
A) The rate of drug elimination is proportional to the drug concentration.
B) A constant amount of drug is eliminated per unit time, regardless of concentration.
C) The drug is eliminated exponentially.
D) The drug's half-life remains constant.
Answer: B) A constant amount of drug is eliminated per unit time, regardless of
concentration.
Rationale: Zero-order kinetics occurs when the elimination mechanisms are saturated, and a
constant amount of drug is eliminated per unit time. This is in contrast to first-order kinetics,
where a constant fraction of the drug is eliminated per unit time (elimination is proportional
to concentration). Alcohol is a classic example of a drug that follows zero-order elimination
at high concentrations.
Question 12:
The blood-brain barrier restricts the entry of drugs into the brain primarily because:
A) Brain capillaries have tight junctions and are surrounded by astrocytic foot processes.
B) There is no blood supply to the brain.
C) The brain has no receptors for drugs.
D) Drugs are metabolized before reaching the brain.
Answer: A) Brain capillaries have tight junctions and are surrounded by astrocytic foot
processes.
Rationale: The blood-brain barrier consists of specialized endothelial cells in brain capillaries
that are connected by tight junctions, preventing the free passage of many substances.
Astrocytes (glial cells) contribute to maintaining this barrier. Only lipophilic (lipid-soluble)
drugs can cross the blood-brain barrier and exert central nervous system effects.
Question 13:
